Lutronic Corp
KOSDAQ:085370
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Lutronic Corp
Cash & Cash Equivalents
Lutronic Corp
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
L
|
Lutronic Corp
KOSDAQ:085370
|
Cash & Cash Equivalents
â‚©50B
|
CAGR 3-Years
64%
|
CAGR 5-Years
69%
|
CAGR 10-Years
33%
|
|
Dentium Co Ltd
KRX:145720
|
Cash & Cash Equivalents
â‚©86.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
||
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
Cash & Cash Equivalents
â‚©9.7B
|
CAGR 3-Years
48%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Cash & Cash Equivalents
â‚©45.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Cash & Cash Equivalents
â‚©52.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
115%
|
CAGR 10-Years
N/A
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Cash & Cash Equivalents
â‚©24.3B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
Lutronic Corp
Glance View
Lutronic Corp. engages in the manufacture and sale of aesthetic laser medical devices. The company is headquartered in Goyang, Gyeonggi-Do. The company went IPO on 2006-07-04. Its products are mainly used for skin treatments including melisma, tattoo and soft tissue incision removal, wrinkles reduction, body and face contouring. The firm offers its medical lacers under the brand names of CLARITY, ACCUSCULPT II, eCO2, MOSAIC HP, SPECTRA and others. In addition, it sells facial lotion to clients. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Lutronic Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
50B
KRW
Based on the financial report for Jun 30, 2023, Lutronic Corp's Cash & Cash Equivalents amounts to 50B KRW.
What is Lutronic Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
33%
Over the last year, the Cash & Cash Equivalents growth was 22%. The average annual Cash & Cash Equivalents growth rates for Lutronic Corp have been 64% over the past three years , 69% over the past five years , and 33% over the past ten years .